By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
October 21, 2025 5:13 PM EDT
Medical Herald
Search
  • Health Conditions
    Health ConditionsShow More
    New Protein Strategy Offers Hope Against Neurodegenerative Diseases
    Health Conditions
    AI Technology Uses Tongue Color to Predict Health Issues
    Health Conditions
    HealthTap Collaborates with Lilly for Diabetes Care Access
    Diabetes News
    Amanda Balionis Shares Lessons from Health Struggles
    Health Conditions
    Cat’s Crying Leads to Surprising Vet Diagnosis
    Health Conditions
  • Wellness & Self-Care
    Wellness & Self-CareShow More
    Parent Seeks Help After Son Faces Relentless Bullying
    Mental Health
    Embracing a Healthier Lifestyle in Santa Clarita Valley
    Healthy Living
    Managing Anxiety Before Medical Procedures: Alternatives Explored
    Mental Health
    Tomorrow x Together Collaborates with UNICEF on Mental Health
    Mental Health
    Kimchi: A Spicy Superfood for Heart Health With Caution
    Heart Health
  • Nutrition & Fitness
    Nutrition & FitnessShow More
    The Vitamin Over 50s Should Avoid, According to Experts
    Nutrients & Supplements
    Grab Walmart’s Home Gym for $290—Save Over $1,000!
    Fitness Trends & Tech
    Marian Burros’ Iconic Plum Torte Recipe Makes a Timeless Comeback
    Healthy Recipes
    Cozy Fall and Winter Soup Recipes to Savor
    Healthy Recipes
    Doctors Urge Caution on Excessive Supplement Use
    Nutrients & Supplements
  • Innovation
    InnovationShow More
    Sam’s Club Offers Affordable Ozempic, Wegovy for Weight Loss
    Drugs & Medications
    Annual COVID Vaccines Essential for Severe Disease Protection
    Drugs & Medications
    Covid Booster Shots: Are They Necessary for Younger Adults?
    Drugs & Medications
    Exploring Bidirectional Inheritance in Digital DNA Systems
    Innovation
    Amazon Introduces Prescription Kiosks at One Medical Clinics
    Innovation
  • News
    NewsShow More
    Michigan’s Top Children’s Hospital Celebrates 19 Years of Excellence
    News
    SCV Food Pantry Marks 40 Years of Community Service
    News
    J&J Ordered to Pay $966 Million in Talc Baby Powder Case
    News
    New Diagnostic Facility Opens in Oxford to Enhance Cancer Care
    News
    HealthTap Collaborates with Lilly for Diabetes Care Access
    Diabetes News
Font ResizerAa
Medical HeraldMedical Herald
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Search
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Follow US
Copyright © 2025, Medical Herald. All Rights Reserved.
Home » News » J&J Ordered to Pay $966 Million in Talc Baby Powder Case

J&J Ordered to Pay $966 Million in Talc Baby Powder Case

By Liam Fraser
Published: October 21, 2025
Share

In a landmark ruling, a California jury has mandated Johnson & Johnson (J&J) to compensate the family of Mae Moore a staggering $966 million. This comes after Moore, who passed away in 2021 at the age of 88, attributed her diagnosis of mesothelioma, a cancer linked to asbestos exposure, to her lifelong use of the company’s baby powder.

The verdict was reached late Monday by a jury in Los Angeles, making it the largest award for a single plaintiff in the ongoing 15-year litigation concerning J&J’s talc products. The jury awarded Moore’s family $16 million in compensatory damages, accompanied by an unprecedented $950 million in punitive damages. This decision underscores the jury’s judgment against the company, which was accused of concealing the health risks associated with its beloved powder.

In reaction to the verdict, Erik Haas, Worldwide Vice President of Litigation at J&J, expressed the company’s intention to appeal, labeling the verdict as “egregious and unconstitutional.” He further emphasized that it contradicts the outcomes of the vast majority of previous talc-related cases where J&J has secured favorable results.

This verdict emerges at a critical time for J&J, as the company is preparing for a series of jury trials related to its talc-based baby powder. Notably, the product was removed from the global market in 2023 following mounting legal challenges. J&J has made multiple unsuccessful attempts to leverage bankruptcy courts in an effort to negotiate settlements for the thousands of claims against it.

Jessica Dean, a Texas attorney representing Moore’s family, highlighted the lengthy journey to justice, stating, “It took this family five years to get their day in court and we’re pleased the jury concluded J&J should be held accountable.”

Despite J&J having spent over $3 billion in settling lawsuits that alleged its baby powder contained harmful asbestos, the company still faces more than 70,000 claims linking the product to mesothelioma and ovarian cancers. Many of these cases have been grouped together in New Jersey under a federal judge for pre-trial proceedings.

Historically, juries have found J&J and its spinoff, Kenvue, liable for cancer cases related to their baby powder, awarding billions in damages. However, several of these financial awards have been reduced or overturned through appeals.

J&J has consistently maintained that its talc products are safe and devoid of asbestos, asserting that the powder has been marketed responsibly for over a century. Nonetheless, court documents presented by plaintiffs suggest internal J&J communications indicated the company may have been aware of potential asbestos presence in its talc products since the early 1970s.

The 2018 case against J&J, which resulted in a $4.7 billion jury award to 20 women in Missouri, stands as the largest verdict against the company to date. That award was later reduced to $2.1 billion on appeal, with J&J ultimately paying around $2.5 billion with interest.

Experts believe that Moore’s award should also expect a reduction. According to Bloomberg Intelligence analyst Holly Froum, U.S. Supreme Court guidelines stipulate that punitive damages should not exceed ten times the compensatory damages to be deemed reasonable.

Court filings indicate that Moore used J&J’s baby powder and the Shower-to-Shower powder variant for approximately 80 years. The jury concluded that J&J had deliberately failed to inform users like Moore about the cancer risks associated with its products. It is worth noting that J&J sold Shower-to-Shower to Valeant Pharmaceuticals for around $150 million in 2012.

The case is officially recorded as Moore v. J&J, JCCP 4674, 21STCV055134, in the California Superior Court (Los Angeles).Diseases & Conditions

Share This Article
Facebook LinkedIn Email Copy Link
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

HOT NEWS

New Protein Strategy Offers Hope Against Neurodegenerative Diseases

October 21, 2025

The Vitamin Over 50s Should Avoid, According to Experts

Experts warn adults over 50 to avoid excessive Vitamin A and B6 supplements, citing risks…

October 21, 2025

Sam’s Club Offers Affordable Ozempic, Wegovy for Weight Loss

Sam’s Club launches $499 pricing for Ozempic and Wegovy, expanding access to weight-loss meds and…

October 21, 2025

Annual COVID Vaccines Essential for Severe Disease Protection

A new study reveals COVID boosters cut deaths by 64% and hospitalizations by 39%, offering…

October 21, 2025

YOU MAY ALSO LIKE

Michigan’s Top Children’s Hospital Celebrates 19 Years of Excellence

C.S. Mott Children’s Hospital ranks No. 1 in Michigan for the 19th year, recognized for excellence in cancer, cardiology, diabetes,…

October 21, 2025

Cassandra Peterson Unveils ‘Elvira’s Cookbook from Hell’

Elvira’s new cookbook brings frightful flavor to your kitchen with real, horror-themed recipes, personal stories, and a dash of campy…

October 3, 2025

Eataly Launches in King of Prussia Mall with Italian Delights

Eataly opens its long-awaited King of Prussia Mall location, featuring authentic Italian food, wine, and a 200-seat restaurant for Philly…

October 7, 2025

Ovechkin Teams Up with Young Cancer Patient for Special Event

Alex Ovechkin’s GR8 CHASE initiative unites hockey and hope, raising funds for pediatric cancer while inspiring young fighters like 4-year-old…

October 20, 2025

Medical Herald is your trusted source for medical news, scientific research, health policy updates, and expert insights from around the world. 

Category

  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
  • Privacy Policy
  • About Us
  • Contact

Follow US: 

  • Grow Big Agency Sites:
  • London Business Journal
Copyright © 2025, Medical Herald. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?